Life Sciences Panel

This panel of leading Silicon Valley venture capitalists discussing Lifescience investing gives a rich snapshot of developments in the field between 2002 and 2004. The panel covers current and historical trends in public and private investing in biotechnology and medical devices, where Sand Hill is investing and what it looks for in a management team, the impact of liquidation preferences on VC investing and exit opportunities, management incentives and the impact of dilution, the importance of product differentiation, the role of the FDA in life sciences, and entrepreneurship in the context of changes in the broader U.S. health care system. Panel includes: Jonathan J. MacQuitty (Abingworth Management), Craig Taylor (Alloy Ventures), Barbara Santry (Capstone Ventures), Geoffrey Duyk (TPG), Mark Edwards (Recombinant Capital and Moderator)
Recorded: February 21, 2004

Category:

Education